Login Register Cart 0
Generic placeholder image

Current Diabetes Reviews

Editor-in-Chief

ISSN (Print): 1573-3998
ISSN (Online): 1875-6417

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Insulin Resistance is Associated with Clinical Manifestations of Diabetic Kidney Disease (Glomerular Hyperfiltration, Albuminuria, and Kidney Function Decline)

Author(s): María M. Adeva-Andany*, Carlos Fernández-Fernández, Raquel Funcasta-Calderón, Eva Ameneiros-Rodríguez, Lucía Adeva-Contreras and Elvira Castro-Quintela

Volume 18, Issue 7, 2022

Published on: 18 January, 2022

Article ID: e171121197998 Pages: 22

DOI: 10.2174/1573399818666211117122604

Price: $65

Abstract

Clinical features of diabetic kidney disease include glomerular hyperfiltration, albuminuria, and kidney function decline towards End-Stage Kidney Disease (ESKD). There are presently neither specific markers of kidney involvement in patients with diabetes nor strong predictors of rapid progression to ESKD. Serum-creatinine-based equations used to estimate glomerular filtration rate are notoriously unreliable in patients with diabetes. Early kidney function decline, reduced glomerular filtration rate, and proteinuria contribute to identifying diabetic patients at higher risk for rapid kidney function decline. Unlike proteinuria, the elevation of urinary albumin excretion in the range of microalbuminuria is frequently transient in patients with diabetes and does not always predict progression towards ESKD. Although the rate of progression of kidney function decline is usually accelerated in the presence of proteinuria, histological lesions of diabetes and ESKD may occur with normal urinary albumin excretion. No substantial reduction in the rate of ESKD associated with diabetes has been observed during the last decades despite intensified glycemic control and reno-protective strategies, indicating that existing therapies do not target underlying pathogenic mechanisms of kidney function decline. Very long-term effects of sodium-glucose transporters- 2 inhibitors and glucagon-like peptide-1 analogs remain to be defined. In patients with diabetes, glucagon secretion is typically elevated and induces insulin resistance. Insulin resistance is consistently and strongly associated with clinical manifestations of diabetic kidney disease, suggesting that reduced insulin sensitivity participates in the pathogenesis of the disease and may represent a therapeutic objective. Amelioration of insulin sensitivity in patients with diabetes is associated with cardioprotective and kidney-protective effects.

Keywords: Glomerular hyperfiltration, albuminuria, chronic kidney disease, glucagon, glomerular filtration rate, metabolic syndrome, hypertension, serum triglycerides.

[1]
Grams ME, Sang Y, Levey AS, et al. Kidney-failure risk projection for the living kidney-donor candidate. N Engl J Med 2016; 374(5): 411-21.
[http://dx.doi.org/10.1056/NEJMoa1510491] [PMID: 26544982]
[2]
de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011; 305(24): 2532-9.
[http://dx.doi.org/10.1001/jama.2011.861] [PMID: 21693741]
[3]
Haneda M, Utsunomiya K, Koya D, et al. A new classification of Diabetic Nephropathy 2014: A report from Joint Committee on Diabetic Nephropathy. Clin Exp Nephrol 2015; 19(1): 1-5.
[http://dx.doi.org/10.1007/s10157-014-1057-z] [PMID: 25527479]
[4]
Ruggenenti P, Porrini EL, Gaspari F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012; 35(10): 2061-8.
[http://dx.doi.org/10.2337/dc11-2189] [PMID: 22773704]
[5]
Forsblom C, Harjutsalo V, Thorn LM, et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011; 22(3): 537-44.
[http://dx.doi.org/10.1681/ASN.2010020194] [PMID: 21335512]
[6]
Krolewski AS, Skupien J, Rossing P, Warram JH. Fast renal decline to end-stage renal disease: An unrecognized feature of nephropathy in diabetes. Kidney Int 2017; 91(6): 1300-11.
[http://dx.doi.org/10.1016/j.kint.2016.10.046] [PMID: 28366227]
[7]
Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? further evidence from the pittsburgh epidemiology of diabetes complication study. Kidney Int 2002; 62(3): 963-70.
[http://dx.doi.org/10.1046/j.1523-1755.2002.00507.x] [PMID: 12164879]
[8]
Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 2006; 55(6): 1832-9.
[http://dx.doi.org/10.2337/db05-1620] [PMID: 16731850]
[9]
Bjornstad P, Snell-Bergeon JK, Rewers M, et al. Early diabetic nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes. Diabetes Care 2013; 36(11): 3678-83.
[http://dx.doi.org/10.2337/dc13-0631] [PMID: 24026551]
[10]
Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51(5): 1580-7.
[http://dx.doi.org/10.2337/diabetes.51.5.1580] [PMID: 11978659]
[11]
Adeva-Andany MM, Funcasta-Calderón R, Fernández-Fernández C, Ameneiros-Rodríguez E, Domínguez-Montero A. Subclinical vascular disease in patients with diabetes is associated with insulin resistance. Diabetes Metab Syndr 2019; 13(3): 2198-206.
[http://dx.doi.org/10.1016/j.dsx.2019.05.025] [PMID: 31235157]
[12]
Rosolowsky ET, Skupien J, Smiles AM, et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011; 22(3): 545-53.
[http://dx.doi.org/10.1681/ASN.2010040354] [PMID: 21355053]
[13]
Myers VC, Bailey CV. The Lewis and Benedict method for the estimation of blood sugar, with some observations obtained in disease. J Biol Chem 1916; 24: 161-74.
[http://dx.doi.org/10.1016/S0021-9258(18)87566-4]
[14]
DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67(2): 563-8.
[http://dx.doi.org/10.1172/JCI110067] [PMID: 7007440]
[15]
Schmitz O, Alberti KG, Christensen NJ, et al. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 1985; 34(5): 465-73.
[http://dx.doi.org/10.1016/0026-0495(85)90213-6] [PMID: 3887103]
[16]
Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 2005; 45(2): 275-80.
[http://dx.doi.org/10.1053/j.ajkd.2004.09.034] [PMID: 15685504]
[17]
Nerpin E, Risérus U, Ingelsson E, et al. Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 2008; 31(8): 1550-5.
[http://dx.doi.org/10.2337/dc08-0369] [PMID: 18509205]
[18]
Xu H, Huang X, Arnlöv J, et al. Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4. Clin J Am Soc Nephrol 2014; 9(4): 690-7.
[http://dx.doi.org/10.2215/CJN.05230513] [PMID: 24436478]
[19]
de Boer IH, Zelnick L, Afkarian M, et al. Impaired glucose and insulin homeostasis in moderate-severe CKD. J Am Soc Nephrol 2016; 27(9): 2861-71.
[http://dx.doi.org/10.1681/ASN.2015070756] [PMID: 26823551]
[20]
Melsom T, Stefansson V, Schei J, et al. Association of increasing GFR with change in albuminuria in the general population. Clin J Am Soc Nephrol 2016; 11(12): 2186-94.
[http://dx.doi.org/10.2215/CJN.04940516] [PMID: 27683625]
[21]
Melsom T, Nair V, Schei J, et al. Correlation between baseline gfr and subsequent change in gfr in norwegian adults without diabetes and in pima indians. Am J Kidney Dis 2019; 73(6): 777-85.
[http://dx.doi.org/10.1053/j.ajkd.2018.11.011] [PMID: 30704883]
[22]
Hoy WE, Douglas-Denton RN, Hughson MD, Cass A, Johnson K, Bertram JF. A stereological study of glomerular number and volume: Preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl 2003; (83): S31-7.
[http://dx.doi.org/10.1046/j.1523-1755.63.s83.8.x] [PMID: 12864872]
[23]
Turer CB, Baum M, Dubourg L, Selistre LS, Skinner AC. Prevalence of hyperfiltration among US youth/young adults with overweight and obesity: A population-based association study. Obes Sci Pract 2019; 5(6): 570-80.
[http://dx.doi.org/10.1002/osp4.365] [PMID: 31890248]
[24]
Stalder G, Schmid R. Severe functional disorders of glomerular capillaries and renal hemodynamics in treated diabetes mellitus during childhood. Ann Paediatr 1959; 193: 129-38.
[PMID: 13833669]
[25]
Ditzel J, Schwartz M. Abnormally increased glomerular filtration rate in short-term insulin-treated diabetic subjects. Diabetes 1967; 16(4): 264-7.
[http://dx.doi.org/10.2337/diab.16.4.264] [PMID: 6023168]
[26]
Mogensen CE. Kidney function and glomerular permeability to macromolecules in early juvenile diabetes. Scand J Clin Lab Invest 1971; 28(1): 79-90.
[http://dx.doi.org/10.3109/00365517109090666] [PMID: 5093522]
[27]
Mogensen CE, Andersen MJ. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment. Diabetologia 1975; 11(3): 221-4.
[http://dx.doi.org/10.1007/BF00422325] [PMID: 1149954]
[28]
Mogensen CE. Renal function changes in diabetes. Diabetes 1976; 25(2 SUPPL)(Suppl.): 872-9.
[PMID: 971791]
[29]
Wiseman MJ, Saunders AJ, Keen H, Viberti G. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312(10): 617-21.
[http://dx.doi.org/10.1056/NEJM198503073121004] [PMID: 3883162]
[30]
Molitch ME, Gao X, Bebu I, et al. Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: The DCCT/EDIC experience. Clin J Am Soc Nephrol 2019; 14(6): 854-61.
[http://dx.doi.org/10.2215/CJN.14831218] [PMID: 31123181]
[31]
Myers BD, Nelson RG, Williams GW, et al. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 1991; 88(2): 524-30.
[http://dx.doi.org/10.1172/JCI115335] [PMID: 1864963]
[32]
Vora JP, Dolben J, Dean JD, et al. Renal hemodynamics in newly presenting non-insulin dependent diabetes mellitus. Kidney Int 1992; 41(4): 829-35.
[http://dx.doi.org/10.1038/ki.1992.127] [PMID: 1513105]
[33]
Silveiro SP, Friedman R, Gross JL. Glomerular hyperfiltration in NIDDM patients without overt proteinuria. Diabetes Care 1993; 16(1): 115-9.
[http://dx.doi.org/10.2337/diacare.16.1.115] [PMID: 8422764]
[34]
Nelson RG, Bennett PH, Beck GJ, et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. N Engl J Med 1996; 335(22): 1636-42.
[http://dx.doi.org/10.1056/NEJM199611283352203] [PMID: 8929360]
[35]
Chaiken RL, Eckert-Norton M, Bard M, et al. Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 1998; 21(12): 2129-34.
[http://dx.doi.org/10.2337/diacare.21.12.2129] [PMID: 9839105]
[36]
Bjornstad P, Maahs DM, Cherney DZ, et al. Insulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes. Diabetes Care 2014; 37(11): 3033-9.
[http://dx.doi.org/10.2337/dc14-1331] [PMID: 25071077]
[37]
Müller WA, Faloona GR, Unger RH. Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med 1973; 54(1): 52-7.
[http://dx.doi.org/10.1016/0002-9343(73)90083-1] [PMID: 4629972]
[38]
Raskin P, Pietri A, Unger R. Changes in glucagon levels after four to five weeks of glucoregulation by portable insulin infusion pumps. Diabetes 1979; 28(11): 1033-5.
[http://dx.doi.org/10.2337/diab.28.11.1033] [PMID: 488544]
[39]
Parving HH, Christiansen JS, Noer I, Tronier B, Mogensen CE. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia 1980; 19(4): 350-4.
[http://dx.doi.org/10.1007/BF00280519] [PMID: 7429061]
[40]
Nowack R, Raum E, Blum W, Ritz E. Renal hemodynamics in recent-onset type II diabetes. Am J Kidney Dis 1992; 20(4): 342-7.
[http://dx.doi.org/10.1016/S0272-6386(12)70296-2] [PMID: 1415201]
[41]
Parving HH, Noer J, Kehlet H, Mogensen CE, Svendsen PA, Heding L. The effect of short-term glucagon infusion on kidney function in normal man. Diabetologia 1977; 13(4): 323-5.
[http://dx.doi.org/10.1007/BF01223273] [PMID: 334617]
[42]
Schmidt A, Pleiner J, Schaller G, et al. Renal hemodynamic effects of somatostatin are not related to inhibition of endogenous insulin release. Kidney Int 2002; 61(5): 1788-93.
[http://dx.doi.org/10.1046/j.1523-1755.2002.00320.x] [PMID: 11967028]
[43]
Serri O, Beauregard H, Brazeau P, et al. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265(7): 888-92.
[http://dx.doi.org/10.1001/jama.1991.03460070070045] [PMID: 1992187]
[44]
Rudberg S, Dahlqvist G, Aperia A, et al. Indications that branched chain amino acids, in addition to glucagon, affect the glomerular filtration rate after a high protein diet in insulin-dependent diabetes. Diabetes Res 1991; 16(3): 101-9.
[PMID: 1802476]
[45]
Mohamed A, Wilkin T, Leatherdale BA, Rowe D. Response of urinary albumin to submaximal exercise in newly diagnosed non-insulin dependent diabetes. Br Med J (Clin Res Ed) 1984; 288(6427): 1342-3.
[http://dx.doi.org/10.1136/bmj.288.6427.1342-a] [PMID: 6424850]
[46]
Uusitupa M, Siitonen O, Penttilä I, Aro A, Pyörälä K. Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 1987; 10(2): 191-4.
[http://dx.doi.org/10.2337/diacare.10.2.191] [PMID: 3556105]
[47]
Marshall SM, Alberti KG. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Q J Med 1989; 70(261): 61-71.
[PMID: 2594949]
[48]
Schmitz A, Hansen HH, Christensen T. Kidney function in newly diagnosed type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 1989; 32(7): 434-9.
[http://dx.doi.org/10.1007/BF00271263] [PMID: 2806767]
[49]
Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W. Morbidity, mortality, and albuminuria in type 2 diabetic patients: A three-year prospective study of a random cohort in general practice. Diabet Med 1992; 9(7): 646-53.
[http://dx.doi.org/10.1111/j.1464-5491.1992.tb01861.x] [PMID: 1511572]
[50]
Standl E, Stiegler H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the greater Munich area. Diabetologia 1993; 36(10): 1017-20.
[http://dx.doi.org/10.1007/BF02374493] [PMID: 8243849]
[51]
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63(1): 225-32.
[http://dx.doi.org/10.1046/j.1523-1755.2003.00712.x] [PMID: 12472787]
[52]
Bjornstad P, Costacou T, Miller RG, et al. Predictors of early renal function decline in adults with type 1 diabetes: The coronary artery calcification in type 1 diabetes and the pittsburgh epidemiology of diabetes complications studies. Diabet Med 2017; 34(11): 1532-40.
[http://dx.doi.org/10.1111/dme.13430] [PMID: 28734104]
[53]
Martin P, Hampton KK, Walton C, Tindall H, Davies JA. Microproteinuria in type 2 diabetes mellitus from diagnosis. Diabet Med 1990; 7(4): 315-8.
[http://dx.doi.org/10.1111/j.1464-5491.1990.tb01396.x] [PMID: 1692521]
[54]
Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients. Kidney Int 1982; 21(5): 730-8.
[http://dx.doi.org/10.1038/ki.1982.90] [PMID: 7109459]
[55]
Olivarius NdeF, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes Care in General Practice”, Denmark. Diabetologia 1993; 36(10): 1007-16.
[http://dx.doi.org/10.1007/BF02374492] [PMID: 8243848]
[56]
UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 1993; 36(10): 1021-9.
[PMID: 8243850]
[57]
Rossing P, Rossing K, Gaede P, Pedersen O, Parving HH. Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy. Diabetes Care 2006; 29(5): 1024-30.
[http://dx.doi.org/10.2337/dc05-2201] [PMID: 16644632]
[58]
Gaspari F, Ruggenenti P, Porrini E, et al. The GFR and GFR decline cannot be accurately estimated in type 2 diabetics. Kidney Int 2013; 84(1): 164-73.
[http://dx.doi.org/10.1038/ki.2013.47] [PMID: 23447062]
[59]
Miki A, Hashimoto Y, Matsumoto S, et al. Protein intake, especially vegetable protein intake, is associated with higher skeletal muscle mass in elderly patients with type 2 diabetes. J Diabetes Res 2017; 2017: 7985728.
[http://dx.doi.org/10.1155/2017/7985728] [PMID: 29209633]
[60]
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33(4): 278-85.
[http://dx.doi.org/10.1111/j.1532-5415.1985.tb07117.x] [PMID: 3989190]
[61]
Eriksen BO, Stefansson VTN, Jenssen TG, et al. Elevated blood pressure is not associated with accelerated glomerular filtration rate decline in the general non-diabetic middle-aged population. Kidney Int 2016; 90(2): 404-10.
[http://dx.doi.org/10.1016/j.kint.2016.03.021] [PMID: 27188503]
[62]
Tsalamandris C, Allen TJ, Gilbert RE, et al. Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 1994; 43(5): 649-55.
[http://dx.doi.org/10.2337/diab.43.5.649] [PMID: 8168641]
[63]
Vistisen D, Andersen GS, Hulman A, Persson F, Rossing P, Jørgensen ME. Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function-even without albuminuria. Diabetes Care 2019; 42(10): 1886-94.
[http://dx.doi.org/10.2337/dc19-0349] [PMID: 31221677]
[64]
Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH. Progression of diabetic nephropathy. Kidney Int 2001; 59(2): 702-9.
[http://dx.doi.org/10.1046/j.1523-1755.2001.059002702.x] [PMID: 11168952]
[65]
Molitch ME, Steffes M, Sun W, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010; 33(7): 1536-43.
[http://dx.doi.org/10.2337/dc09-1098] [PMID: 20413518]
[66]
Zoppini G, Targher G, Chonchol M, et al. Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol 2012; 7(3): 401-8.
[http://dx.doi.org/10.2215/CJN.07650711] [PMID: 22282481]
[67]
Perkins BA, Ficociello LH, Ostrander BE, et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol 2007; 18(4): 1353-61.
[http://dx.doi.org/10.1681/ASN.2006080872] [PMID: 17329575]
[68]
Krolewski AS, Niewczas MA, Skupien J, et al. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care 2014; 37(1): 226-34.
[http://dx.doi.org/10.2337/dc13-0985] [PMID: 23939543]
[69]
Bjornstad P, Cherney DZ, Snell-Bergeon JK, et al. Rapid GFR decline is associated with renal hyperfiltration and impaired GFR in adults with Type 1 diabetes. Nephrol Dial Transplant 2015; 30(10): 1706-11.
[http://dx.doi.org/10.1093/ndt/gfv121] [PMID: 26050268]
[70]
Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG. Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol 2012; 7(1): 78-84.
[http://dx.doi.org/10.2215/CJN.07610711] [PMID: 22076874]
[71]
Oshima M, Toyama T, Haneda M, et al. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLoS One 2018; 13(8): e0201535.
[http://dx.doi.org/10.1371/journal.pone.0201535] [PMID: 30071057]
[72]
So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006; 29(9): 2046-52.
[http://dx.doi.org/10.2337/dc06-0248] [PMID: 16936151]
[73]
Ninomiya T, Perkovic V, de Galan BE, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009; 20(8): 1813-21.
[http://dx.doi.org/10.1681/ASN.2008121270] [PMID: 19443635]
[74]
Amin AP, Whaley-Connell AT, Li S, Chen SC, McCullough PA, Kosiborod MN. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2013; 61(4)(Suppl. 2): S12-23.
[http://dx.doi.org/10.1053/j.ajkd.2013.01.005] [PMID: 23507266]
[75]
Stefan G, Stancu S, Zugravu A, Petre N, Mandache E, Mircescu G. Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification. Medicine (Baltimore) 2019; 98(27): e16333.
[http://dx.doi.org/10.1097/MD.0000000000016333] [PMID: 31277183]
[76]
Koye DN, Magliano DJ, Reid CM, et al. Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: The CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2018; 72(5): 653-61.
[http://dx.doi.org/10.1053/j.ajkd.2018.02.364] [PMID: 29784612]
[77]
Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 1996; 45(12): 1729-33.
[http://dx.doi.org/10.2337/diab.45.12.1729] [PMID: 8922358]
[78]
Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Nephrology (Carlton) 2012; 17(1): 68-75.
[http://dx.doi.org/10.1111/j.1440-1797.2011.01525.x] [PMID: 21933307]
[79]
Nowak N, Skupien J, Smiles AM, et al. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int 2018; 93(5): 1198-206.
[http://dx.doi.org/10.1016/j.kint.2017.11.024] [PMID: 29398132]
[80]
Buyadaa O, Magliano DJ, Salim A, Koye DN, Shaw JE. Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes. Diabetes Care 2020; 43(1): 122-9.
[http://dx.doi.org/10.2337/dc19-1438] [PMID: 31796570]
[81]
Yokoyama H, Araki SI, Kawai K, et al. The prognosis of patients with type 2 diabetes and nonalbuminuric diabetic kidney disease is not always poor: Implication of the effects of coexisting macrovascular complications (JDDM 54). Diabetes Care 2020; 43(5): 1102-10.
[http://dx.doi.org/10.2337/dc19-2049] [PMID: 32144168]
[82]
Steele DJ, Yeron RG, Abendroth C, Diamond JR. Diabetic glomerulosclerosis and chronic renal failure with absent-to-minimal microalbuminuria. Am J Kidney Dis 1992; 20(1): 80-3.
[http://dx.doi.org/10.1016/S0272-6386(12)80322-2] [PMID: 1621684]
[83]
Lane PH, Steffes MW, Mauer SM. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 1992; 41(5): 581-6.
[http://dx.doi.org/10.2337/diab.41.5.581] [PMID: 1568527]
[84]
Berg UB, Torbjörnsdotter TB, Jaremko G, Thalme B. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 1998; 41(9): 1047-56.
[http://dx.doi.org/10.1007/s001250051029] [PMID: 9754823]
[85]
Caramori ML, Kim Y, Huang C, et al. Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 2002; 51(2): 506-13.
[http://dx.doi.org/10.2337/diabetes.51.2.506] [PMID: 11812762]
[86]
Budhiraja P, Thajudeen B, Popovtzer M. Absence of albuminuria in type 2 diabetics with classical diabetic nephropathy. Clinical pathological study. J Biomed Sci Eng 2013; 6: 20-5.
[http://dx.doi.org/10.4236/jbise.2013.65A005]
[87]
Costacou T, Ellis D, Fried L, Orchard TJ. Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: A cohort study. Am J Kidney Dis 2007; 50(5): 721-32.
[http://dx.doi.org/10.1053/j.ajkd.2007.08.005] [PMID: 17954285]
[88]
Thorn LM, Gordin D, Harjutsalo V, et al. The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes. Diabetes Care 2015; 38(11): 2128-33.
[http://dx.doi.org/10.2337/dc15-0641] [PMID: 26310691]
[89]
Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA 2003; 289(24): 3273-7.
[http://dx.doi.org/10.1001/jama.289.24.3273] [PMID: 12824208]
[90]
Kramer CK, Leitão CB, Pinto LC, Silveiro SP, Gross JL, Canani LH. Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria. Diabetes Care 2007; 30(8): 1998-2000.
[http://dx.doi.org/10.2337/dc07-0387] [PMID: 17468344]
[91]
Afghahi H, Cederholm J, Eliasson B, et al. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes-the Swedish National Diabetes Register (NDR). Nephrol Dial Transplant 2011; 26(4): 1236-43.
[http://dx.doi.org/10.1093/ndt/gfq535] [PMID: 20817668]
[92]
Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 2011; 29(9): 1802-9.
[http://dx.doi.org/10.1097/HJH.0b013e3283495cd6] [PMID: 21738053]
[93]
Rigalleau V, Lasseur C, Raffaitin C, et al. Normoalbuminuric renal-insufficient diabetic patients: A lower-risk group. Diabetes Care 2007; 30(8): 2034-9.
[http://dx.doi.org/10.2337/dc07-0140] [PMID: 17485574]
[94]
Schmieder RE, Veelken R, Gatzka CD, Rüddel H, Schächinger H. Predictors for hypertensive nephropathy: Results of a 6-year follow-up study in essential hypertension. J Hypertens 1995; 13(3): 357-65.
[http://dx.doi.org/10.1097/00004872-199503000-00012] [PMID: 7622857]
[95]
Tomaszewski M, Charchar FJ, Maric C, et al. Glomerular hyperfiltration: A new marker of metabolic risk. Kidney Int 2007; 71(8): 816-21.
[http://dx.doi.org/10.1038/sj.ki.5002160] [PMID: 17332732]
[96]
Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 2012; 27(5): 1821-5.
[http://dx.doi.org/10.1093/ndt/gfr651] [PMID: 22140135]
[97]
Park M, So R, Joo KW, Yoon HJ. Association between lower serum bicarbonate and renal hyperfiltration in the general population with preserved renal function: A cross-sectional study. BMC Nephrol 2016; 17: 3.
[http://dx.doi.org/10.1186/s12882-015-0218-y] [PMID: 26739690]
[98]
Kawata I, Koshi T, Hirabayashi K, et al. Prediabetes defined by the international expert committee as a risk for development of glomerular hyperfiltration. Acta Diabetol 2019; 56(5): 525-9.
[http://dx.doi.org/10.1007/s00592-019-01287-9] [PMID: 30707298]
[99]
Lee AM, Charlton JR, Carmody JB, Gurka MJ, DeBoer MD. Metabolic risk factors in nondiabetic adolescents with glomerular hyperfiltration. Nephrol Dial Transplant 2017; 32(9): 1517-24.
[PMID: 27312148]
[100]
Kelishadi R, Qorbani M, Assadi F, et al. Glomerular Hyperfiltration as Predictor of Cardiometabolic Risk Factors among Children and Adolescents: The Childhood and Adolescence Surveillance and Prevention of Adult-V Study. Int J Prev Med 2018; 9: 33.
[http://dx.doi.org/10.4103/ijpvm.IJPVM_38_18] [PMID: 29619157]
[101]
Cox HJ, Bhandari S, Rigby AS, Kilpatrick ES. Mortality at low and high estimated glomerular filtration rate values: A ‘U’ shaped curve. Nephron Clin Pract 2008; 110(2): c67-72.
[http://dx.doi.org/10.1159/000151720] [PMID: 18758185]
[102]
Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375(9731): 2073-81.
[http://dx.doi.org/10.1016/S0140-6736(10)60674-5] [PMID: 20483451]
[103]
Tonelli M, Klarenbach SW, Lloyd AM, et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int 2011; 80(12): 1306-14.
[http://dx.doi.org/10.1038/ki.2011.280] [PMID: 21849971]
[104]
Reboldi G, Verdecchia P, Fiorucci G, et al. Glomerular hyperfiltration is a predictor of adverse cardiovascular outcomes. Kidney Int 2018; 93(1): 195-203.
[http://dx.doi.org/10.1016/j.kint.2017.07.013] [PMID: 28935213]
[105]
Eriksen BO, Løchen ML, Arntzen KA, et al. Subclinical cardiovascular disease is associated with a high glomerular filtration rate in the nondiabetic general population. Kidney Int 2014; 86(1): 146-53.
[http://dx.doi.org/10.1038/ki.2013.470] [PMID: 24304885]
[106]
Parving HH, Noer I, Deckert T, et al. The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 1976; 12(2): 161-6.
[http://dx.doi.org/10.1007/BF00428983] [PMID: 1269850]
[107]
Bjornstad P, Nehus E, El Ghormli L, et al. Insulin sensitivity and diabetic kidney disease in children and adolescents with type 2 diabetes: An observational analysis of data from the TODAY clinical trial. Am J Kidney Dis 2018; 71(1): 65-74.
[http://dx.doi.org/10.1053/j.ajkd.2017.07.015] [PMID: 29157731]
[108]
Ruggenenti P, Abbate M, Ruggiero B, et al. Renal and systemic effects of calorie restriction in patients with type 2 diabetes with abdominal obesity: A randomized controlled trial. Diabetes 2017; 66(1): 75-86.
[http://dx.doi.org/10.2337/db16-0607] [PMID: 27634224]
[109]
Mogensen CE. Elevated glomerular filtration rate in insulin-treated short-term diabetes. Non-dependence on blood sugar value. Acta Med Scand 1973; 194(6): 559-61.
[PMID: 4773457]
[110]
Schmitz A, Christensen T, Taagehoej Jensen F. Glomerular filtration rate and kidney volume in normoalbuminuric non-insulin-dependent diabetics-lack of glomerular hyperfiltration and renal hypertrophy in uncomplicated NIDDM. Scand J Clin Lab Invest 1989; 49(2): 103-8.
[http://dx.doi.org/10.3109/00365518909105406] [PMID: 2520361]
[111]
Mogensen CE, Andersen MJ. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22(9): 706-12.
[http://dx.doi.org/10.2337/diab.22.9.706] [PMID: 4728209]
[112]
Ficociello LH, Perkins BA, Roshan B, et al. Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes. Diabetes Care 2009; 32(5): 889-93.
[http://dx.doi.org/10.2337/dc08-1560] [PMID: 19196883]
[113]
Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR, Groop LC. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995; 38(3): 363-9.
[http://dx.doi.org/10.1007/BF00400643] [PMID: 7758885]
[114]
Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998; 47(5): 793-800.
[http://dx.doi.org/10.2337/diabetes.47.5.793] [PMID: 9588452]
[115]
Fujikawa R, Okubo M, Egusa G, Kohno N. Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 Years follow up study. Diabetes Res Clin Pract 2001; 53(2): 99-106.
[http://dx.doi.org/10.1016/S0168-8227(01)00241-8] [PMID: 11403858]
[116]
Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The Inter-Tribal Heart Project. J Am Soc Nephrol 2002; 13(6): 1626-34.
[http://dx.doi.org/10.1097/01.ASN.0000015762.92814.85] [PMID: 12039992]
[117]
Chen J, Muntner P, Hamm LL, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 2004; 140(3): 167-74.
[http://dx.doi.org/10.7326/0003-4819-140-3-200402030-00007] [PMID: 14757614]
[118]
Bonnet F, Marre M, Halimi JM, et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: The DESIR Study. J Hypertens 2006; 24(6): 1157-63.
[http://dx.doi.org/10.1097/01.hjh.0000226206.03560.ac] [PMID: 16685216]
[119]
Viberti G, Bognetti E, Wiseman MJ, Dodds R, Gross JL, Keen H. Effect of protein-restricted diet on renal response to a meat meal in humans. Am J Physiol 1987; 253(3 Pt 2): F388-93.
[PMID: 3631277]
[120]
Fioretto P, Trevisan R, Valerio A, et al. Impaired renal response to a meat meal in insulin-dependent diabetes: Role of glucagon and prostaglandins. Am J Physiol 1990; 258(3 Pt 2): F675-83.
[PMID: 2316671]
[121]
Mogensen CE. Urinary albumin excretion in early and long-term juvenile diabetes. Scand J Clin Lab Invest 1971; 28(2): 183-93.
[http://dx.doi.org/10.3109/00365517109086899] [PMID: 5130106]
[122]
Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 1986; 315(4): 215-9.
[http://dx.doi.org/10.1056/NEJM198607243150402] [PMID: 3523245]
[123]
Dahlquist G, Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 1987; 76(5): 795-800.
[http://dx.doi.org/10.1111/j.1651-2227.1987.tb10567.x] [PMID: 3661181]
[124]
Amin R, Turner C, van Aken S, et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The oxford regional prospective study. Kidney Int 2005; 68(4): 1740-9.
[http://dx.doi.org/10.1111/j.1523-1755.2005.00590.x] [PMID: 16164650]
[125]
Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 342(8876): 883-7.
[http://dx.doi.org/10.1016/0140-6736(93)91943-G] [PMID: 8105164]
[126]
Girgis CM, Scalley BD, Park KE. Utility of the estimated glucose disposal rate as a marker of microvascular complications in young adults with type 1 diabetes. Diabetes Res Clin Pract 2012; 96(3): e70-2.
[http://dx.doi.org/10.1016/j.diabres.2012.02.004] [PMID: 22385830]
[127]
Bjornstad P, Maahs DM, Johnson RJ, Rewers M, Snell-Bergeon JK. Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes. Diabet Med 2015; 32(2): 257-61.
[http://dx.doi.org/10.1111/dme.12572] [PMID: 25303233]
[128]
Rudberg S, Dahlquist G. Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care 1996; 19(4): 369-71.
[http://dx.doi.org/10.2337/diacare.19.4.369] [PMID: 8729162]
[129]
Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med 2003; 348(23): 2285-93.
[http://dx.doi.org/10.1056/NEJMoa021835] [PMID: 12788992]
[130]
Thorn LM, Forsblom C, Fagerudd J, et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 28(8): 2019-24.
[http://dx.doi.org/10.2337/diacare.28.8.2019] [PMID: 16043748]
[131]
Damsgaard EM, Mogensen CE. Microalbuminuria in elderly hyperglycaemic patients and controls. Diabet Med 1986; 3(5): 430-5.
[http://dx.doi.org/10.1111/j.1464-5491.1986.tb00785.x] [PMID: 2951194]
[132]
Chan JC, Tomlinson B, Nicholls MG, et al. Albuminuria, insulin resistance and dyslipidaemia in Chinese patients with non-insulin-dependent diabetes (NIDDM). Diabet Med 1996; 13(2): 150-5.
[http://dx.doi.org/10.1002/(SICI)1096-9136(199602)13:2<150::AID-DIA33>3.0.CO;2-J] [PMID: 8641120]
[133]
Takahashi N, Anan F, Nakagawa M, et al. Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus. Metabolism 2004; 53(10): 1359-64.
[http://dx.doi.org/10.1016/j.metabol.2004.03.024] [PMID: 15375795]
[134]
De Cosmo S, Minenna A, Ludovico O, et al. Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: Evidence of a sex-specific association. Diabetes Care 2005; 28(4): 910-5.
[http://dx.doi.org/10.2337/diacare.28.4.910] [PMID: 15793194]
[135]
Parvanova AI, Trevisan R, Iliev IP, et al. Insulin resistance and microalbuminuria: A cross-sectional, case-control study of 158 patients with type 2 diabetes and different degrees of urinary albumin excretion. Diabetes 2006; 55(5): 1456-62.
[http://dx.doi.org/10.2337/db05-1484] [PMID: 16644705]
[136]
Hsu CC, Chang HY, Huang MC, et al. Association between insulin resistance and development of microalbuminuria in type 2 diabetes: A prospective cohort study. Diabetes Care 2011; 34(4): 982-7.
[http://dx.doi.org/10.2337/dc10-1718] [PMID: 21335369]
[137]
Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001; 44(9): 1148-54.
[http://dx.doi.org/10.1007/s001250100615] [PMID: 11596670]
[138]
Migdalis IN, Papanas N, Raptis AE, Ioannidis IM, Sotiropoulos AE, Dimitriadis GD. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics. Diabetes Res Clin Pract 2020; 166: 108243.
[http://dx.doi.org/10.1016/j.diabres.2020.108243] [PMID: 32502694]
[139]
Nelson RG, Morgenstern H, Bennett PH. An epidemic of proteinuria in Pima Indians with type 2 diabetes mellitus. Kidney Int 1998; 54(6): 2081-8.
[http://dx.doi.org/10.1046/j.1523-1755.1998.00191.x] [PMID: 9853273]
[140]
de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Arch Intern Med 2011; 171(5): 412-20.
[http://dx.doi.org/10.1001/archinternmed.2011.16] [PMID: 21403038]
[141]
Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005; 54(7): 2164-71.
[http://dx.doi.org/10.2337/diabetes.54.7.2164] [PMID: 15983218]
[142]
Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications 2013; 27(2): 123-7.
[http://dx.doi.org/10.1016/j.jdiacomp.2012.09.010] [PMID: 23182925]
[143]
Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16(7): 2134-40.
[http://dx.doi.org/10.1681/ASN.2005010106] [PMID: 15901764]
[144]
Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ. Plasma lipids and risk of developing renal dysfunction: The atherosclerosis risk in communities study. Kidney Int 2000; 58(1): 293-301.
[http://dx.doi.org/10.1046/j.1523-1755.2000.00165.x] [PMID: 10886574]
[145]
Chen J, Muntner P, Hamm LL, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003; 14(2): 469-77.
[http://dx.doi.org/10.1097/01.ASN.0000046029.53933.09] [PMID: 12538749]
[146]
Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “Double diabetes” in the diabetes control and complications trial. Diabetes Care 2007; 30(3): 707-12.
[http://dx.doi.org/10.2337/dc06-1982] [PMID: 17327345]
[147]
Jorsal A, Tarnow L, Frystyk J, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int 2008; 74(5): 649-54.
[http://dx.doi.org/10.1038/ki.2008.201] [PMID: 18496510]
[148]
Emoto M, Nishizawa Y, Maekawa K, et al. Insulin resistance in non-obese, non-insulin-dependent diabetic patients with diabetic nephropathy. Metabolism 1997; 46(9): 1013-8.
[http://dx.doi.org/10.1016/S0026-0495(97)90271-7] [PMID: 9284889]
[149]
de Boer IH, Sun W, Cleary PA, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011; 365(25): 2366-76.
[http://dx.doi.org/10.1056/NEJMoa1111732] [PMID: 22077236]
[150]
Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial. Lancet 2010; 376(9739): 419-30.
[http://dx.doi.org/10.1016/S0140-6736(10)60576-4] [PMID: 20594588]
[151]
Thomson HJ, Ekinci EI, Radcliffe NJ, et al. Elevated baseline Glomerular Filtration Rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes. J Diabetes Complications 2016; 30(2): 256-61.
[http://dx.doi.org/10.1016/j.jdiacomp.2015.11.003] [PMID: 26794645]
[152]
Moriya T, Tanaka S, Sone H, et al. Patients with type 2 diabetes having higher glomerular filtration rate showed rapid renal function decline followed by impaired glomerular filtration rate: japan diabetes complications study. J Diabetes Complications 2017; 31(2): 473-8.
[http://dx.doi.org/10.1016/j.jdiacomp.2016.06.020] [PMID: 27396240]
[153]
Low S, Zhang X, Wang J, et al. Long-term prospective observation suggests that glomerular hyperfiltration is associated with rapid decline in renal filtration function: A multiethnic study. Diab Vasc Dis Res 2018; 15(5): 417-23.
[http://dx.doi.org/10.1177/1479164118776465] [PMID: 29807475]

Rights & Permissions Print Cite
Article Metrics
48
1
© 2024 Bentham Science Publishers | Privacy Policy